A Small Niche Pharma Company
A 540 Cr Market Cap company, operating in a niche space. The founder is a technocrat with 38 years of experience in the Pharma Industry. With the recent demerger, we think that it is going to unlock the shareholder’s value. The company is posting consistently good numbers but the market hasn’t rewarded it yet in …